Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

AM-251 and Rimonabant Act as Direct Antagonists at Mu-Opioid — 2012 Animal Study - Veterinary Clinical Trial | BudProfiles

Home

Studies

AM-251 and Rimonabant Act as Direct Antagonists at...

InconclusiveAnimal Study - Veterinary Clinical Trial2012

AM-251 and Rimonabant Act as Direct Antagonists at Mu-Opioid Receptors: Implications for Opioid/Cannabinoid Interaction Studies

View Study

Classification Results

AI Classification

Inconclusive

Fine-tuned Classification

N/A

Conditions Studied

Addiction - Opioid

Related Studies

Inconclusive

Global burden of disease due to opioid, amphetamine, cocaine, and cannabis use disorders, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

2025·Review/Other

Inconclusive

Cannabis Use in Opioid Maintenance Therapy: Prevalence, Clinical Correlates and Reasons for Use

2025·Review/Other

Inconclusive

Clinical and psychosocial changes in adults with opioid use disorder and chronic pain using medical cannabis: a brief report

2025·Review/Other

Inconclusive

Suicide Risk Among Cannabis, Heroin and Cocaine Users

2025·Review/Other

Inconclusive

Cortical Complexity Alterations in Methamphetamine, Cannabis, and Opioid Users: An EEG-Based Analysis

2025·Review/Other

Inconclusive

Clinicians’ attitudes and knowledge of medicinal cannabis in opioid dependence treatment clinics in New South Wales, Australia

2025·Review/Other

Cannabinoids

AM-x Synthetic CannabinoidsSR-x Synthetic Cannabinoids

Organ Systems

Nervous System

Study Details

Type: Animal Study - Veterinary Clinical Trial
Year: 2012
Study ID: #2012068